NVNO MEXC RealStocks
Own real NVNO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:04:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
enVVeno Medical Corporation (NVNO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $5.76, with a market capitalization of $4.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.56 to $14.67. This page covers its latest market performance, valuation, price trends and company information.
$4.13M | |
$5.77 | |
$6.86 | |
$5.56 | |
$5.77 | |
12.50K | |
30.29K | |
-- | |
$14.67 | |
$5.56 | |
-- | |
2026-09-30 |
enVVeno Medical Corporation (NVNO) last closed at $5.76 as of 2026-11-19 00:31:00, down 0.17% ($0.01) from the previous close of $5.77.
During the latest regular trading session, NVNO traded between $5.56 and $6.86, with a volume of 12.50K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, enVVeno Medical Corporation (NVNO) moved from $6.85 to $5.76, representing a decline of 15.91% ($1.09).
The stock traded between $5.56 and $7.56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 9.52 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.2%
NVNO is currently trading at $5.76, placing it 2.2% of the way from its 52-week low of $5.56 to its 52-week high of $14.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 33 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of enVVeno Medical Corporation (NVNO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NVNO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NVNO shares and USD.
NVNO Shares to USD
1.00 NVNO shares = 5.76 USD
Calculations are estimates based on the latest available price and are for reference only.